60
Participants
Start Date
August 29, 2022
Primary Completion Date
October 23, 2023
Study Completion Date
October 23, 2028
A244
Dose of A244 is 300μg. Vaccine will be administered via IM injection into the same deltoid muscle (same side) for all injections at Month 0 (Day 1), Month 1 (Day 29), and Month 2 (Day 57).
B.63521
Dose of B.63521 is 300μg. Vaccine will be administered via IM injection into the same deltoid muscle (same side) for all injections at Month 0 (Day 1), Month 1 (Day 29), and Month 2 (Day 57).
50μg ALFQ
Dose of ALFQ is 50μg. Vaccine will be administered via IM injection into the same deltoid muscle (same side) for all injections at Month 0 (Day 1), Month 1 (Day 29), and Month 2 (Day 57).
100μg ALFQ
Dose of ALFQ is 100μg. Vaccine will be administered via IM injection into the same deltoid muscle (same side) for all injections at Month 0 (Day 1), Month 1 (Day 29), and Month 2 (Day 57).
200μg ALFQ
Dose of ALFQ is 200μg. Vaccine will be administered via IM injection into the same deltoid muscle (same side) for all injections at Month 0 (Day 1), Month 1 (Day 29), and Month 2 (Day 57).
RECRUITING
Walter Reed Army Institute of Research, Clinical Trials Center, Silver Spring
US Military HIV Research Program
NETWORK
Henry M. Jackson Foundation for the Advancement of Military Medicine
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
U.S. Army Medical Research and Development Command
FED